๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Maternal DNA hypomethylation and congenital heart defects

โœ Scribed by Shimul Chowdhury; Mario A. Cleves; Stewart L. MacLeod; S. Jill James; Weizhi Zhao; Charlotte A. Hobbs


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
152 KB
Volume
91
Category
Article
ISSN
1542-0752

No coin nor oath required. For personal study only.

โœฆ Synopsis


BACKGROUND: Congenital heart defects (CHDs) are among the most prevalent and serious of birth defects. Multiple maternal factors are thought to contribute to CHD development, including folate intake. Maternal DNA methylation, which is dependent on folate metabolism, may impact the risk of CHDs. Our study was designed to determine whether maternal long interspersed nucleotide elements-1 (LINE-1) DNA hypomethylation is associated with increased occurrence of non-syndromic CHDs and whether maternal folate-dependent metabolites are correlated with DNA methylation status. METHODS: Using a case-control study design, we measured global DNA methylation status among mothers whose pregnancies were affected by non-syndromic CHDs (n 5 180) and mothers of unaffected pregnancies (n 5 187). Methylation of LINE-1 was used as a surrogate marker of global DNA methylation status. The association between DNA methylation and CHD risk was determined while adjusting for selected lifestyle factors. RESULTS: LINE-1 DNA methylation was significantly lower in cases compared to controls (p 5 0.049). After covariate adjustments, a significant difference between cases and controls remained (p 5 0.010). Among women with LINE-1 methylation in the lowest decile of DNA methylation, the estimated risk of having a CHD-affected pregnancy was almost twice that of women in all other deciles (odds ratio [OR], 1.91; 95% confidence interval [CI], 1.03-3.58). CONCLU- SIONS: Our findings indicate that maternal LINE-1 DNA hypomethylation is associated with an increased risk of CHDs. Future studies investigating the association between maternal DNA methylation patterns and CHDs should be pursued. Birth Defects Research (Part A) 91: 69-76, 2011.


๐Ÿ“œ SIMILAR VOLUMES


Congenital heart defects and maternal ge
โœ Charlotte A. Hobbs; Stewart L. MacLeod; S. Jill James; Mario A. Cleves ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 301 KB ๐Ÿ‘ 1 views

## BACKGROUND: The purpose of this study was to identify metabolic, genetic, and lifestyle factors that discriminate between women who have pregnancies affected by congenital heart defects (CHDs) from those who have unaffected pregnancies. METHODS: We analyzed the concentrations of 13 serum biomar

Trichloroethylene exposure and congenita
โœ Anthony R. Scialli; Herman Gibb ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 42 KB

In their study on trichloroethylene (TCE) exposure and congenital heart defects (CHDs), conclude, ". . . our observations add significantly to the overall body of literature that suggests TCE is a cardiac teratogen." This conclusion is too strong. The method of identifying exposure involved materna

Maternal asthma, asthma medication use,
โœ Shao Lin; Michele Herdt-Losavio; Lenore Gensburg; Elizabeth Marshall; Charlotte ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB ๐Ÿ‘ 1 views

## Abstract **BACKGROUND:** Asthma is a common problem that complicates pregnancy. Several drugs are considered acceptable for use during pregnancy, although none have been classified as safe. Few studies have assessed the health impact of maternal asthma/medication use on the fetus. **METHODS:** A